Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| CHU Liège - Belgium | UNKNOWN |
Not provided
Not provided
Not provided
The aim of the present study is to evaluate the effects of training performed with the LUNA-EMG system to enhance motor functions of the upper limb in stroke This is a randomized open-label trial. Patients will be randomized into the intervention group (LUNA-EMG) or in the control group (standard care).
The effect of the training will be measured with the EMG, the upper limb motor function and the quality of life.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| LUNA-EMG | Experimental | The experimental group will receive 30 minutes of training with the LUNA-EMG for 12 weeks. |
|
| Control | No Intervention | The control group will receive its rehabilitation care. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| LUNA-EMG | Device | The LUNA-EMG (Samcom) system is a robot that allows the evaluation of muscular strength through the recording of muscle activity (electromyography - EMG) in order to provide precise objective data on the patient's muscle function. In addition to the diagnostic aspect (evaluation of muscle strength, range of motion and proprioception), the LUNA-EMG robot allows the adaptation of movements during rehabilitation sessions according to the individually generated strength. |
| Measure | Description | Time Frame |
|---|---|---|
| muscular strength in mV | muscular strength will be measured with the EMG | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Fugl-Meyer | The scale evaluates motor capacities of the upper limb following a stroke. Scores range from 0 to 66 (the higher the better). | 12 weeks |
| Modified Ashworth Scale | This scale measures spasticity. The results are scored from 0 to 4 (the higher the more spastic). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CNRF | Tinlot | Liege | 4557 | Belgium |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 12 weeks |
| Lovett | This scale measures muscular strength. The scale ranges from 0 to 5 (the higher the better). | 12 weeks |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |